Arrowhead's subsidiary Visirna has entered an agreement with Sanofi for plozasiran, a potential treatment for hypertriglyceridemia.

President Donald Trump's warnings about pharmaceutical tariffs have triggered a wave of manufacturing commitments from major ...

The Centre has made it mandatory to print QR codes on the packaging of the top 300 drug brands that sell medicines in India.